Abstract 2962: Molecular mechanisms underlying the sensitizing effect of mutant p53 protein expression for Auranofin treatment of NSCLC and PDAC cells

Author(s):  
Laurie Freire Boullosa ◽  
Filip Lardon ◽  
Evelien Smits ◽  
Christophe Deben
2021 ◽  
Vol Volume 13 ◽  
pp. 4129-4134
Author(s):  
Ming Tang ◽  
Peng-Jie Liu ◽  
Bing Yue ◽  
Xuan-Tao Yang ◽  
Guang-Yong Chen

2015 ◽  
Vol 5 ◽  
Author(s):  
Reshma Vijayakumaran ◽  
Kah Hin Tan ◽  
Panimaya Jeffreena Miranda ◽  
Sue Haupt ◽  
Ygal Haupt

2018 ◽  
Vol 9 (3) ◽  
pp. 171-178
Author(s):  
Riani Erna

Background: Mutant p53 protein  is produced by  mutant p53 gene,  this protein takes part in tissue hyperplasia process in pterygium.  Triamcinolone acetonide in often use to reduce reccurency.  Besides decreasing the inflamation triamcinolone acetonide is assumed to be able to repair the function of p53 gene.  Thus, it  reactivates cell apoptosis system and prevent the tissue hyperplasia process in pterygium.To compare Mutant p53 Protein Expression  in Pterygium Group With and Without Triamcinolone Acetonide InjectionMethods: This research is a randomized clinical trial study consists of 31 subject who suffered primary pterygium. All subject divided into 2 grup with and without triamcinolone acetonide injection. After excision the pterygium and the tissue were examined through histopatology and immunohistochemical with Hematcoycline Eosin and reagent  Clone DO7 staining to see the mutant p53 protein expression.Results: Mutant p53 protein expression in triamcinolone acetonite injected group is 0% and non  triamcinolone acetonite injected group is 33,33%Conclusion: Mutant p53 protein expression in triamconolone acetonite  injected group is lower than non injected grou. Keywords: Mutant  p53 protein,  primary pterygium, triamcinolone acetonide  immunohistochemicial  


2005 ◽  
Vol 288 (3) ◽  
pp. L488-L496 ◽  
Author(s):  
Liying Wang ◽  
Linda Bowman ◽  
Yongju Lu ◽  
Yon Rojanasakul ◽  
Robert R. Mercer ◽  
...  

Occupational exposure to mineral dusts, such as silica, has been associated with progressive pulmonary inflammation, lung cancer, and fibrosis. However, the mechanisms involved in this process are poorly understood. Because p53 is a key transcription factor regulating many important apoptosis-related genes, we hypothesized that p53 may play a key role in silica-induced apoptosis and that abnormal regulation of p53 by silica may contribute to development of lung cancer as well as silicosis. We used both in vitro and in vivo studies to test this hypothesis. Treatment of JB6 cells carrying a p53-luciferase reporter plasmid with silica caused dose-dependent p53 transactivation. Western blot indicates that silica not only stimulated p53 protein expression but also caused p53 phosphorylation at Ser392. TUNEL and DNA fragmentation analysis show that silica caused apoptosis in both JB6 cells and wild-type p53 ( p53+/+) fibroblasts but not in p53-deficient ( p53−/−) fibroblasts. Similar results were obtained by in vivo studies. Intratracheal instillation of mice with silica induced apoptosis in the lung of p53+/+ mice, whereas this induction was significantly inhibited in p53−/− mice. Confocal image analysis indicates that most apoptotic cells induced by silica were alveolar macrophages. These results demonstrate for the first time that silica induces p53 transactivation via induction of p53 protein expression and phosphorylation of p53 protein and that p53 plays a crucial role in the signal transduction pathways of silica-induced apoptosis. This finding may provide an important link in understanding the molecular mechanisms of silica-induced carcinogenesis and pathogenesis in the lung.


2018 ◽  
Vol 9 (3) ◽  
pp. 171-178
Author(s):  
Riani Erna

Background: Mutant p53 protein  is produced by  mutant p53 gene,  this protein takes part in tissue hyperplasia process in pterygium.  Triamcinolone acetonide in often use to reduce reccurency.  Besides decreasing the inflamation triamcinolone acetonide is assumed to be able to repair the function of p53 gene.  Thus, it  reactivates cell apoptosis system and prevent the tissue hyperplasia process in pterygium.To compare Mutant p53 Protein Expression  in Pterygium Group With and Without Triamcinolone Acetonide InjectionMethods: This research is a randomized clinical trial study consists of 31 subject who suffered primary pterygium. All subject divided into 2 grup with and without triamcinolone acetonide injection. After excision the pterygium and the tissue were examined through histopatology and immunohistochemical with Hematcoycline Eosin and reagent  Clone DO7 staining to see the mutant p53 protein expression.Results: Mutant p53 protein expression in triamcinolone acetonite injected group is 0% and non  triamcinolone acetonite injected group is 33,33%Conclusion: Mutant p53 protein expression in triamconolone acetonite  injected group is lower than non injected grou. Keywords: Mutant  p53 protein,  primary pterygium, triamcinolone acetonide  immunohistochemicial  


Oncogene ◽  
1998 ◽  
Vol 16 (25) ◽  
pp. 3269-3277 ◽  
Author(s):  
Runzhao Li ◽  
Patrick D Sutphin ◽  
Dov Schwartz ◽  
Devorah Matas ◽  
Nava Almog ◽  
...  

2020 ◽  
Author(s):  
S Ben Slama ◽  
D Bacha ◽  
A Ben Amor ◽  
A Halouani ◽  
A Lahmar

1995 ◽  
Vol 24 (1) ◽  
pp. 18-22 ◽  
Author(s):  
J. A. Regezi ◽  
R. J. Zarbo ◽  
E. Regev ◽  
S. Pisanty ◽  
S. Silverman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document